Organigram Global Inc

Análisis de la acción Organigram Global Inc (OGI)

$0.930

-0.034 (-3.65%)Al cierre

Loading chart…
Máximo
0.980
Apertura
0.980
Precio medio ponderado por volumen
0.93
Volumen
1.66M
Capitalización
164.80M
Mínimo
0.890
Importe
1.55M
EV/EBITDA, TTM
3.03

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

www.organigram.ca

Análisis de IA of Organigram Global Inc (OGI)

Comprar

OrganiGram Holdings Inc is a good buy right now due to its recent strong performance, with a current price of 0.9651 and a significant gross margin of 23.06% in Q3 2026. The stock has shown a 5-day change of +2.78% and a projected trajectory indicating a potential increase of +105.64% based on historical patterns. However, investors should be cautious of the risk posed by a high forward P/E ratio of 14.66, which may indicate overvaluation if growth does not materialize as expected.

Métricas de valoración

El PER previsto actual de Organigram Global Inc (OGI) es 15.02, frente a su media de 5 años de 1.47.

PER previsto

Valor razonable
Media 5A P/E
1.47
P/E actual
15.02
Sobrevalorada
49.92
Infravalorada
-46.97

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-34.26
EV/EBITDA actual
3.03
Sobrevalorada
201.70
Infravalorada
-270.23

Precio/ventas previsto

Infravalorado
Media 5A P/S
1.59
P/S actual
0.30
Sobrevalorada
2.78
Infravalorada
0.39

Escenarios de precio de Alphio AI para OGI

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%OGI

$1.86

Precio del escenario

B

Base

Base · 50%OGI

$1.64

Precio del escenario

B

Bajista

Bajista · 25%OGI

$1.37

Precio del escenario

Cronología de eventos

2026-11-03 (ET)

16:30:00

Apple Warns of Margin Drop, Mixed Day for Markets

12:00:00

Apple Warns of Margin Drop, Markets Mixed

09:30:00

Organigram to Acquire Aurora at C$7.80 per Share, Valuing Transaction at Approximately C$561 Million

09:30:00

Organigram to Acquire Aurora Cannabis for C$7.80 per Share

08:30:00

Organigram Holdings Trading Halted, News Pending

Noticias

Preguntas frecuentes sobre OGI, respondidas por Alphio AI

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).

OrganiGram Holdings Inc is a good buy right now due to its recent strong performance, with a current price of 0.9651 and a significant gross margin of 23.06% in Q3 2026. The stock has shown a 5-day change of +2.78% and a projected trajectory indicating a potential increase of +105.64% based on historical patterns. However, investors should be cautious of the risk posed by a high forward P/E ratio of 14.66, which may indicate overvaluation if growth does not materialize as expected.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar